Home Contact Us    عربي  
About Us Products QC Marketing News Activities Therapeutic Areas Useful Links
Home Page > Products by Alphabet > CYPROHEPTADINE-BARAKAT
   
 
 
  Brand name: CYPROHEPTADINE-BARAKAT  
  Formula: Tablets    
  Categories: Antihistamines  
  Code: 12-5  
  Composition:

Each tablet contains: 
Cyproheptadine Hydrochloride  4 mg

 
 
  Detailed Information:

INDICATIONS:
- Perennial and seasonal allergic rhinitis
- Vasomotor rhinitis
- Allergic conjunctivitis due to inhalant allergens and foods
- Mild, uncomplicated allergic skin manifestations of urticaria and angioedema
- Amelioration of allergic reactions to blood or plasma
- Cold urticaria
- As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.
CONTRAINDICATIONS:
- This drug should not be used in newborn or premature infants.
- Antihistamine therapy is contraindicated in nursing mothers.
- Hypersensitivity to cyproheptadine and other drugs of similar chemical structure: Monoamine oxidase inhibitor therapy, Angle-closure glaucoma, Stenosing peptic ulcer, Symptomatic prostatic hypertrophy, Bladder neck obstruction, Pyloroduodenal obstruction, Elderly, debilitated patients.
SIDE EFFECTS :
Central Nervous System: Sedation and sleepiness (often transient), dizziness, disturbed coordination, confusion, restlessness, excitation, nervousness, tremor, irritability, insomnia, paresthesias, neuritis, convulsions, euphoria, hallucinations, hysteria, faintness.
Integumentary: Allergic manifestation of rash and edema, excessive perspiration, urticaria, photosensitivity.
Special Senses: Acute labyrinthitis, blurred vision, diplopia, vertigo, tinnitus.
Cardiovascular: Hypotension, palpitation, tachycardia, extrasystoles, anaphylactic shock.
Hematologic: Hemolytic anemia, leukopenia, agranulocytosis, thrombocytopenia.
Digestive System: Cholestasis, hepatic failure, hepatitis, hepatic function abnormality, dryness of mouth, epigastric distress, nausea, vomiting, diarrhea, constipation, jaundice.
Genitourinary: Urinary frequency, difficult urination, urinary retention, early menses.
Respiratory: Dryness of nose and throat, thickening of bronchial secretions, tightness of chest and wheezing, nasal stuffiness.
Miscellaneous: Fatigue, chills, headache, increased appetite/weight gain.
DOSAGE & ADMINISTRATION :
DOSAGE SHOULD BE INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE PATIENT.
Pediatric Patients: Age 2 to 6 years: The total daily dosage for pediatric patients may be calculated on the basis of body weight or body area using approximately 0.25 mg/kg/day or 8 mg per square meter of body surface (8 mg/m 2).
The usual dose is 2 mg (1 teaspoonful) two or three times a day, adjusted as necessary to the size and response of the patient. The dose is not to exceed 12 mg a day.
Age 7 to 14 years: The usual dose is 4 mg (1 tablet) two or three times a day, adjusted as necessary to the size and response of the patient. The dose is not to exceed 16 mg a day.
Adults: The total daily dose for adults should not exceed 0.5 mg/kg/day.
The therapeutic range is 4 to 20 mg a day, with the majority of patients requiring 12 to 16 mg a day. An occasional patient may require as much as 32 mg a day for adequate relief. It is suggested that dosage be initiated with 4 mg (1 tablet) three times a day and adjusted according to the size and response of the patient.
PRESENTATION:
Carton box containing: 20 tablets.

 
   
 
About Us | Products | Quality Control | Marketing | What's New? | Activities